nach oben

Erschienen in:

01.02.2024 | Refraktionsfehler | CME

Globale Ophthalmologie

Aktueller Stand

verfasst von: Dr. Heiko Philippin, MD PhD, Enyam K. A. Morny, Sven P. Heinrich, Ingrid Töws, Philip C. Maier, Rudolf F. Guthoff, Babar M. Qureshi, Thomas Reinhard, Matthew J. Burton, Robert P. Finger

Erschienen in: Die Ophthalmologie | Ausgabe 2/2024

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die globale Ophthalmologie hat zum Ziel, das Sehvermögen, die Augengesundheit und die Funktionsfähigkeit weltweit zu maximieren. Sie trägt so zur allgemeinen Gesundheit, zum Wohlbefinden, zur sozialen Teilhabe und zur Lebensqualität eines jeden Einzelnen bei. Derzeit leben geschätzte 1,1 Mrd. Menschen mit einer Sehbehinderung, welche in 90 % der Fälle durch größtenteils kosteneffiziente Maßnahmen präveniert oder kuriert werden kann. Gleichzeitig leben 90 % der betroffenen Menschen in Regionen mit einer unzureichenden augenmedizinischen Versorgung. Diese Herausforderung war für die World Health Organization (WHO) und eine Gruppe von Nichtregierungsorganisationen der Anstoß für die globale Initiative VISION 2020, die nach 20 Jahren abgeschlossen wurde. Erfolge, Herausforderungen und Lehren daraus wurden herausgearbeitet und flossen in die aktuelle Kampagne 2030 IN SIGHT.

Burton MJ, Ramke J, Marques AP et al (2021) The lancet global health commission on global eye health: vision beyond 2020. Lancet Glob Health 9:e489–e551. https://doi.org/10.1016/S2214-109X(20)30488-5CrossRefPubMedPubMedCentral

Bourne R, Steinmetz JD, Flaxman S et al (2021) Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Health 9:e130–e143. https://doi.org/10.1016/S2214-109X(20)30425-3CrossRef

Finger RP (2007) Cataracts in India: current situation, access, and barriers to services over time. Ophthalmic Epidemiol 14:112–118. https://doi.org/10.1080/09286580601114967CrossRefPubMed

Cicinelli MV, Buchan JC, Nicholson M et al (2023) Cataracts. Lancet 401:377–389. https://doi.org/10.1016/S0140-6736(22)01839-6CrossRefPubMed

Finger RP, Kupitz DG, Holz FG et al (2011) Regular provision of outreach increases acceptance of cataract surgery in south India: regular provision of outreach increases acceptance. Trop Med Int Health 16:1268–1275. https://doi.org/10.1111/j.1365-3156.2011.02835.xCrossRefPubMed

Rono H, Bastawrous A, Macleod D et al (2021) Effectiveness of an mHealth system on access to eye health services in Kenya: a cluster-randomised controlled trial. Lancet Digit Health 3:e414–e424. https://doi.org/10.1016/S2589-7500(21)00083-2CrossRefPubMedPubMedCentral

Awan Z (2022) Technology-enabled primary eye health care in Pakistan. Community Eye Health 35:19–20PubMedPubMedCentral

Khan AA, Talpur KI, Awan Z et al (2022) Improving equity, efficiency and adherence to referral in Pakistan’s eye health programmes: pre- and post-pandemic onset. Front Public Health. https://doi.org/10.3389/fpubh.2022.873192CrossRefPubMedPubMedCentral

Choudhari NS, Mundhe G, Khanna R et al (2019) Toward better health outcomes in rural and under-served areas: L. V. Prasad eye institute’s diagonal model of glaucoma care. Ophthalmic Epidemiol 26:420–429. https://doi.org/10.1080/09286586.2019.1646292CrossRefPubMed

10.

Finger RP, Kupitz DG, Fenwick E et al (2012) The impact of successful cataract surgery on quality of life, household income and social status in south India. PLoS One 7:e44268. https://doi.org/10.1371/journal.pone.0044268CrossRefPubMedPubMedCentralADS

11.

Danquah L, Kuper H, Eusebio C et al (2014) The long term impact of cataract surgery on quality of life, activities and poverty: results from a six year longitudinal study in Bangladesh and the Philippines. PLoS One 9:e94140. https://doi.org/10.1371/journal.pone.0094140CrossRefPubMedPubMedCentralADS

12.

Polack S, Eusebio C, Mathenge W et al (2010) The impact of cataract surgery on health related quality of life in Kenya, the Philippines, and Bangladesh. Ophthalmic Epidemiol 17:387–399. https://doi.org/10.3109/09286586.2010.528136CrossRefPubMed

13.

Polack S, Eusebio C, Mathenge W et al (2010) The impact of cataract surgery on activities and time-use: results from a longitudinal study in Kenya, Bangladesh and the Philippines. PLoS One 5:e10913. https://doi.org/10.1371/journal.pone.0010913CrossRefPubMedPubMedCentralADS

14.

Koplan JP, Bond TC, Merson MH et al (2009) Towards a common definition of global health. Lancet 373:1993–1995. https://doi.org/10.1016/S0140-6736(09)60332-9CrossRefPubMedPubMedCentral

15.

Ramke J, Ah Tong BA, Stern J et al (2022) Defining eye health for everyone. Ophthalmic Physiol Opt 42:1–3. https://doi.org/10.1111/opo.12922CrossRefPubMed

16.

Finger RP (2007) Blindheit in Deutschland: Dimensionen und Perspektiven. Ophthalmologe 104:839–844. https://doi.org/10.1007/s00347-007-1600-3CrossRefPubMed

17.

Finger RP, Schuster AK (2020) Sehen und Sehverlust in Deutschland. Woche des Sehens, Bensheim

18.

Mauschitz MM, Li JQ, Larsen PP et al (2019) Epidemiology of severe visual impairment and blindness of old people in Germany. Ophthalmologe 116:201–212. https://doi.org/10.1007/s00347-019-0853-yCrossRefPubMed

19.

Mactaggart I, Kuper H, Murthy GVS et al (2016) Measuring disability in population based surveys: the interrelationship between clinical impairments and reported functional limitations in Cameroon and India. PLoS ONE 11:e164470. https://doi.org/10.1371/journal.pone.0164470CrossRefPubMedPubMedCentral

20.

Washington Group on Disability Statistics (WG) WG short set on functioning (WG-SS)

21.

Steinmetz JD, Bourne RRA, Briant PS et al (2021) Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the right to sight: an analysis for the global burden of disease study. Lancet Glob Health 9:e144–e160. https://doi.org/10.1016/S2214-109X(20)30489-7CrossRef

22.

Mactaggart I, Wallace S, Ramke J et al (2018) Rapid assessment of avoidable blindness for health service planning. Bull World Health Organ 96:726–728. https://doi.org/10.2471/BLT.18.217794CrossRefPubMedPubMedCentral

23.

Nentwich MM, Klauss V, Wilhelm F (2015) Arbeiten im Heimatland oder an Auswandern Denken. Ophthalmologe 112:429–434. https://doi.org/10.1007/s00347-014-3136-7CrossRefPubMed

24.

Knoll KMM, Philippin H, Makupa W, Nentwich MMM (2019) Emigration—an option for African resident physicians?: Opinions from Tanzania and Ethiopia. Ophthalmologe 116:357–363. https://doi.org/10.1007/s00347-018-0690-4CrossRefPubMed

25.

Holden BA, Fricke TR, Wilson DA et al (2016) Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123:1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006CrossRefPubMed

26.

Fricke TR, Jong M, Naidoo KS et al (2018) Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol 102:855–862. https://doi.org/10.1136/bjophthalmol-2017-311266CrossRefPubMed

27.

Wong WL, Su X, Li X et al (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:e106–e116. https://doi.org/10.1016/S2214-109X(13)70145-1CrossRefPubMed

28.

Jonas JB, Bourne RRA, White RA et al (2014) Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis. Am J Ophthalmol 158:808–815. https://doi.org/10.1016/j.ajo.2014.06.012CrossRefPubMed

29.

Tham Y‑C, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology 121:2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013CrossRefPubMed

30.

Murdoch I, Smith AF, Baker H et al (2020) The cost and quality of life impact of glaucoma in Tanzania: an observational study. PLoS ONE 15:e232796. https://doi.org/10.1371/journal.pone.0232796CrossRefPubMedPubMedCentral

31.

Zhao PY, Rahmathullah R, Stagg BC et al (2018) A worldwide price comparison of glaucoma medications, laser trabeculoplasty, and trabeculectomy surgery. JAMA Ophthalmol 136:1271–1279. https://doi.org/10.1001/jamaophthalmol.2018.3672CrossRefPubMedPubMedCentral

32.

Abdull MM, Gilbert CC, Evans J (2015) Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol 15:111. https://doi.org/10.1186/s12886-015-0097-9CrossRefPubMedPubMedCentral

33.

Ocansey S, Kyei S, Diafo A et al (2016) Cost of the medical management and prescription pattern for primary open angle glaucoma (POAG) in Ghana—a retrospective cross-sectional study from three referral facilities. BMC Health Serv Res 16:282. https://doi.org/10.1186/s12913-016-1528-xCrossRefPubMedPubMedCentral

34.

Philippin H, Matayan E, Knoll KM et al (2021) Selective laser trabeculoplasty versus 0·5 % timolol eye drops for the treatment of glaucoma in Tanzania: a randomised controlled trial. Lancet Glob Health 9:e1589–e1599. https://doi.org/10.1016/S2214-109X(21)00348-XCrossRefPubMedPubMedCentral

35.

International Diabetes Federation (2021) IDF diabetes atlas 2021. International Diabetes Federation, Brussels, Belgium

36.

Wong TY, Cheung CMG, Larsen M et al (2016) Diabetic retinopathy. Nat Rev Dis Primers 2:16012. https://doi.org/10.1038/nrdp.2016.12CrossRefPubMed

37.

Vujosevic S, Aldington SJ, Silva P et al (2020) Screening for diabetic retinopathy: new perspectives and challenges. Lancet Diabetes Endocrinol 8:337–347. https://doi.org/10.1016/S2213-8587(19)30411-5CrossRefPubMed

38.

Cleland CR, Rwiza J, Evans JR et al (2023) Artificial intelligence for diabetic retinopathy in low-income and middle-income countries: a scoping review. BMJ Open Diabetes Res Care 11:e3424. https://doi.org/10.1136/bmjdrc-2023-003424CrossRefPubMedPubMedCentral

39.

Taylor HR, Burton MJ, Haddad D et al (2014) Trachoma. Lancet 384:2142–2152. https://doi.org/10.1016/S0140-6736(13)62182-0CrossRefPubMed

40.

World Health Organization (2000) Global initiative for the elimination of avoidable blindness. World Health Organization, Geneva, Switzerland

41.

World Health Organization (2020) WHO alliance for the global elimination of trachoma by 2020: progress report, 2019. World Health Organization, Geneva, Switzerland

42.

Kluxen G, Hörauf A (2007) Okuläre Onchozerkose: Wolbachien haben eine Schlüsselrolle. Ophthalmologe 104:860–865. https://doi.org/10.1007/s00347-007-1594-xCrossRefPubMed

43.

Klauss V, Schaller UC (2004) Tropenophthalmologie – Prävention und Therapie. Ophthalmologe 101:741–765. https://doi.org/10.1007/s00347-004-1039-8CrossRefPubMed

44.

Gustavsen K, Hopkins A, Sauerbrey M (2011) Onchocerciasis in the Americas: from arrival to (near) elimination. Parasit Vectors 4:205. https://doi.org/10.1186/1756-3305-4-205CrossRefPubMedPubMedCentral

45.

World Health Organization (2007) Eliminating river blindness : making a difference—30 years of research and capacity building in tropical diseases. World Health Organization, Geneva, Switzerland

46.

Lamberton PHL, Cheke RA, Winskill P et al (2015) Onchocerciasis transmission in Ghana: persistence under different control strategies and the role of the simuliid vectors. PLoS Negl Trop Dis 9:e3688. https://doi.org/10.1371/journal.pntd.0003688CrossRefPubMedPubMedCentral

47.

Gilbert C, Foster A (2001) Childhood blindness in the context of VISION 2020—the right to sight. Bull World Health Organ 79:227–232PubMedPubMedCentral

48.

Morjaria P, Massie J, Bastawrous A et al (2022) A school eye health rapid assessment (SEHRA) planning tool: module to survey the magnitude and nature of local needs. BMC Public Health 22:1665. https://doi.org/10.1186/s12889-022-13927-xCrossRefPubMedPubMedCentral

49.

Kong L, Fry M, Al-Samarraie M et al (2012) An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS 16:501–507. https://doi.org/10.1016/j.jaapos.2012.09.004CrossRefPubMed

50.

Braimah IZ, Enweronu-Laryea C, Sackey AH et al (2020) Incidence and risk factors of retinopathy of prematurity in Korle-Bu teaching hospital: a baseline prospective study. BMJ Open 10:e35341. https://doi.org/10.1136/bmjopen-2019-035341CrossRefPubMedPubMedCentral

51.

Wang D, Duke R, Chan RP, Campbell JP (2019) Retinopathy of prematurity in Africa: a systematic review. Ophthalmic Epidemiol 26:223–230. https://doi.org/10.1080/09286586.2019.1585885CrossRefPubMedPubMedCentral

52.

Gilbert C, Rahi J, Eckstein M et al (1997) Retinopathy of prematurity in middle-income countries. Lancet 350:12–14. https://doi.org/10.1016/S0140-6736(97)01107-0CrossRefPubMed

53.

Zhao T, Liu S, Zhang R et al (2022) Global burden of vitamin A deficiency in 204 countries and territories from 1990–2019. Nutrients 14:950. https://doi.org/10.3390/nu14050950CrossRefPubMedPubMedCentral

54.

Dickey H, Ikenwilo D, Norwood P et al (2012) Utilisation of eye-care services: the effect of Scotland’s free eye examination policy. Health Policy 108:286–293. https://doi.org/10.1016/j.healthpol.2012.09.006CrossRefPubMed

55.

Resnikoff S, Lansingh VC, Washburn L et al (2020) Estimated number of ophthalmologists worldwide (international council of ophthalmology update): will we meet the needs? Br J Ophthalmol 104:588–592. https://doi.org/10.1136/bjophthalmol-2019-314336CrossRefPubMed

56.

Morny EKA, Boadi-Kusi SB, Ocansey S et al (2019) Assessing the progress towards achieving “VISION 2020: the right to sight” initiative in Ghana. J Environ Public Health 2019:e3813298. https://doi.org/10.1155/2019/3813298CrossRef

57.

Nentwich MM, Klauß V, Guthoff R (2017) Deutsche Augenheilkunde in Entwicklungsländern. Ophthalmologe 114:794–803. https://doi.org/10.1007/s00347-017-0550-7CrossRefPubMed

58.

Ramke J, Gilbert CE, Lee AC et al (2017) Effective cataract surgical coverage: an indicator for measuring quality-of-care in the context of universal health coverage. PLoS ONE 12:e172342. https://doi.org/10.1371/journal.pone.0172342CrossRefPubMedPubMedCentral

59.

World Health Organization (2022) Report of the 2030 targets on effective coverage of eye care. World Health Organization, Geneva, Switzerland

60.

McCormick I, Butcher R, Evans JR et al (2022) Effective cataract surgical coverage in adults aged 50 years and older: estimates from population-based surveys in 55 countries. Lancet Glob Health 10:e1744–e1753. https://doi.org/10.1016/S2214-109X(22)00419-3CrossRefPubMed

61.

McCormick I, Mactaggart I, Bastawrous A et al (2020) Effective refractive error coverage: an eye health indicator to measure progress towards universal health coverage. Ophthalmic Physiol Opt 40:1–5. https://doi.org/10.1111/opo.12662CrossRefPubMed

62.

United Nations (2015) ransforming our world: the 2030 agenda for sustainable development. United Nations, New York

63.

Zhang JH, Ramke J, Jan C et al (2022) Advancing the sustainable development goals through improving eye health: a scoping review. Lancet Planet Health 6:e270–e280. https://doi.org/10.1016/S2542-5196(21)00351-XCrossRefPubMed

64.

Kuper H, Polack S, Mathenge W et al (2010) Does cataract surgery alleviate poverty? Evidence from a multi-centre intervention study conducted in Kenya, the Philippines and Bangladesh. PLoS One 5:e15431. https://doi.org/10.1371/journal.pone.0015431CrossRefPubMedPubMedCentralADS

65.

Ehrlich JR, Ramke J, Macleod D et al (2021) Association between vision impairment and mortality: a systematic review and meta-analysis. Lancet Glob Health 9:e418–e430. https://doi.org/10.1016/S2214-109X(20)30549-0CrossRefPubMedPubMedCentral

66.

Reed-Jones RJ, Solis GR, Lawson KA et al (2013) Vision and falls: a multidisciplinary review of the contributions of visual impairment to falls among older adults. Maturitas 75:22–28. https://doi.org/10.1016/j.maturitas.2013.01.019CrossRefPubMed

67.

Assi L, Chamseddine F, Ibrahim P et al (2021) A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol 139:526. https://doi.org/10.1001/jamaophthalmol.2021.0146CrossRefPubMed

68.

Luo Y, He P, Guo C et al (2018) Association between sensory impairment and dementia in older adults: evidence from China. J Am Geriatr Soc 66:480–486. https://doi.org/10.1111/jgs.15202CrossRefPubMed

69.

Zheng Y, Wu X, Lin X, Lin H (2017) The prevalence of depression and depressive symptoms among eye disease patients: a systematic review and meta-analysis. Sci Rep 7:46453. https://doi.org/10.1038/srep46453CrossRefPubMedPubMedCentralADS

70.

Crews JE, Chou C‑F, Sekar S, Saaddine JB (2017) The prevalence of chronic conditions and poor health among people with and without vision impairment, aged ≥ 65 years, 2010–2014. Am J Ophthalmol 182:18–30. https://doi.org/10.1016/j.ajo.2017.06.038CrossRefPubMed

71.

Kuper H, Dok AM, Wing K et al (2014) The impact of disability on the lives of children; cross-sectional data including 8,900 children with disabilities and 898,834 children without disabilities across 30 countries. PLoS One 9:e107300. https://doi.org/10.1371/journal.pone.0107300CrossRefPubMedPubMedCentralADS

72.

Hannum E, Zhang Y (2012) Poverty and proximate barriers to learning: vision deficiencies, vision correction and educational outcomes in rural northwest China. World Dev 40:1921–1931. https://doi.org/10.1016/j.worlddev.2012.04.029CrossRefPubMedPubMedCentral

73.

Mercer GD, Lyons P, Bassett K (2019) Interventions to improve gender equity in eye care in low-middle income countries: a systematic review. Ophthalmic Epidemiol 26:189–199. https://doi.org/10.1080/09286586.2019.1574839CrossRefPubMed

74.

Nguyen H, Luca Di Tanna G, Coxon K et al (2023) Associations between vision impairment and driving performance and the effectiveness of vision-related interventions: a systematic review. Transp Res Interdiscip Perspect 17:100753. https://doi.org/10.1016/j.trip.2022.100753CrossRef

75.

World Health Organization (2019) World report on vision. World Health Organization, Geneva, Switzerland

76.

Keel S, Müller A, Block S et al (2021) Keeping an eye on eye care: monitoring progress towards effective coverage. Lancet Glob Health 9:e1460–e1464. https://doi.org/10.1016/S2214-109X(21)00212-6CrossRefPubMedPubMedCentral

77.

World Health Organization (2016) Strategizing national health in the 21st century: a handbook. World Health Organization, Geneva, Switzerland

78.

74th WHA Integrated people-centred eye care, including preventable vision impairment and blindness

79.

International Agency for the Prevention of Blindness (2021) 2030 in sight: ending avoidable sight loss. International Agency for the Prevention of Blindness, London

80.

Zondervan BYM, Msukwa G, Onyango J et al (2020) VISION 2020 LINKS programme: the contribution of health partnerships to reduction in blindness worldwide. Eye News 26:7–12

81.

Torres-Netto EA, Gabel-Obermaier C, Gabel P et al (2021) Twenty years of international council of ophthalmology fellowships: description of the programme and the impact on more than 1100 awardees. Br J Ophthalmol 105:1318–1324. https://doi.org/10.1136/bjophthalmol-2020-316484CrossRefPubMed

82.

Jansen LG, Schultz T, Holz FG et al (2022) Smartphone-basierte Fundusfotografie: Anwendungen und Adapter. Ophthalmologe 119:112–126. https://doi.org/10.1007/s00347-021-01536-9CrossRefPubMed

Titel: Globale Ophthalmologie
Aktueller Stand
verfasst von: Dr. Heiko Philippin, MD PhD
Enyam K. A. Morny
Sven P. Heinrich
Ingrid Töws
Philip C. Maier
Rudolf F. Guthoff
Babar M. Qureshi
Thomas Reinhard
Matthew J. Burton
Robert P. Finger
Publikationsdatum: 01.02.2024
Verlag: Springer Medizin
Schlagwörter: Refraktionsfehler
Katarakt
Glaukom
Makuladegeneration
Diabetische Retinopathie
Fehlsichtigkeit
Augenheilkunde
Erschienen in: Die Ophthalmologie / Ausgabe 2/2024
Print ISSN: 2731-720X
Elektronische ISSN: 2731-7218
DOI: https://doi.org/10.1007/s00347-023-01983-6

Bilaterale Myelin-Oligodendrozyten-Glykoprotein (MOG)-Antikörper-assoziierte Optikusneuritis

Open Access
Optikusneuritis
Kasuistik

Refraktives und visuelles Ergebnis nach kombinierter Explantation einer phaken Hinterkammerlinse und Phakoemulsifikation mit Implantation einer torischen IOL

Open Access
Augenheilkunde
Kasuistik

Stellenwert der Fluoreszenzangiographie zur Differenzierung zwischen einer frühen Stauungspapille und einer Papillitis

Open Access
Uveitis
Originalie

Retinale OCT-Biomarker und neurodegenerative Erkrankungen des zentralen Nervensystems

Biomarker
Leitthema

Retinale optische Kohärenztomographie-Biomarker bei demenziellen Erkrankungen

Demenz
Leitthema

Seltene Ursache einer okklusiven retinalen Vaskulopathie

Open Access
Vaskulitiden
Kasuistik

Neu im Fachgebiet Augenheilkunde

Zirkulierende Tumorzellen bei uvealem Melanom

Aderhautmelanom
Leitthema

Die Erstbeschreibung von Tumorzellen in der Blutbahn erfolgte 1869 durch Thomas Ashworth. Dieser beschrieb in der Blutprobe eines metastasierten Krebskranken „cells identical with those of the cancer itself“ und postulierte, dass diese „may tend …

Elektrophysiologie in der Augenheilkunde

Visuell-evozierte-Potentiale
CME-Artikel

Mit elektrophysiologischen Untersuchungen kann man in der Augenheilkunde die Funktionalität der Neurone der Sehbahn untersuchen. Weil elektrophysiologische Ableitungen von der subjektiven Wahrnehmung und Antwort des Patienten unabhängig sind …

„Liquid biopsy“ bei Retinoblastom

Retinoblastom
Leitthema

Die „liquid biopsy“ spielt eine zunehmend wichtige Rolle bei der Diagnose und Behandlung des Retinoblastoms. Die Möglichkeit der sicheren und unkomplizierten Entnahme und Untersuchung von Kammerwasser aus der Vorderkammer trägt wesentlich zur …

Die „onkologische Spur“: zirkulierende Tumor-DNA beim Aderhautmelanom

Aderhautmelanom
Leitthema

In Körperflüssigkeiten wurde zirkulierende Desoxyribonukleinsäure (DNA) bereits vor mehr als 75 Jahren beschrieben [ 19 ]. Aber erst durch die eindrucksvolle technische Weiterentwicklung im Bereich der Nukleinsäureanalyse in den letzten Jahren ist …

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten